Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 231 - 240 of 280

Selected Filters:
1 March 2022

A Comparative Study of Risk Among Adolescent Girls and Young Women who Accept or Decline PrEP Uptake from a Community-based Mobile Clinic

A poster presented at AIDS 2018 encouraging clinics providing PrEP to include messaging to build adolescent girls and young women's confidence to take ownership of their health.

Research, Service Delivery

Document
1 March 2022

Integrating STI Screening into PrEP Services for Adolescent Girls and Young Women in Two Primary Health Care Facilities in Inner-city Johannesburg: Lessons from prevention options for women evaluation research (POWER)

Slide presentation encouraging providers of PrEP to also discuss STI prevention.

Research, Service Delivery, Testing

Document
1 March 2022

Association Between Contraceptive Use and PrEP Uptake and Continuation in Adolescent Girls and Young Women in Cape Town, South Africa – IAS 2019

This poster examines the results of a study that hypothesized that contraceptive use was associated with PrEP uptake and continuation in young women accessing sexual and reproductive health services from a mobile clinic.

Research, Service Delivery

Document
1 March 2022

Association Between Contraceptive Use and PrEP Uptake and Continuation in Adolescent Girls and Young Women in Cape Town, South Africa – INTEREST 2019

This presentation outlines the results from a study to determine the persistence and patterns of oral PrEP use in African young women.

Research, Service Delivery

Document
1 March 2022

Oral PrEP Delivery Platforms: Are family planning clinics an option?

FP clinics may be an option for oral PrEP delivery for AGYW. This poster presents findings from an evaluation of PrEP uptake and provision at public and private family planning settings in Kisumu, Kenya.

Research, Service Delivery

Document
1 March 2022

Adolescent Girls’ PrEP Uptake from a Community-based Mobile Clinic: Early lessons from the POWER demonstration project

This presentation highlights lessons learnt from the POWER demonstration project on Adolescent girls’ PrEP uptake from a community-based mobile clinic

Research, Service Delivery

Document
1 February 2022

Digital Health Landscaping Report

This landscape analysis aimed to identify common virtual channels used in several countries, estimate the number of users of each channel, and categorize countries into one of three groups based on potential for interventions to use virtual channels to succeed. Users were defined as adolescent girls and young women (aged 15–24), pregnant or breastfeeding people…

Demand Creation/Marketing, Service Delivery

Document
1 August 2021

Service Delivery Strategy for the Dual Prevention Pill

Slide presentation providing recommendations for a phased implementation of the dual prevention pill in Kenya, South Africa and Zimbabwe.

Community/Advocacy, Service Delivery

Document
1 August 2021

Private Sector Analysis for the DPP in Kenya and RSA

Slide presentation discussing the readiness and potential of private sector channels (clinics, pharmacies, doctors' offices) in providing a dual prevention pill in Kenya and South Africa.

Demand Creation/Marketing, Financing & Costing, Research, Service Delivery

Document
1 May 2021

Health Care Provider Training for New HIV Prevention Products

This presentation was developed to inform the development of training curricula for new biomedical HIV prevention products. It provides summary insights from an analysis of provider training systems in Kenya, South Africa, and Zimbabwe developed for introduction of the dapivirine vaginal ring in 2020 – 2021.

Service Delivery

Document